Properties of human neutral bronchial mucins after modification of the peptide or the carbohydrate moieties.
Trypsin and pronase treatment of purified human neutral bronchial mucins released small fragments from the C-terminal end of these molecules and resulted in slight increases in their sedimentation coefficient presumably reflecting conformational changes. The antigenic determinant of neutral bronchial mucins which appears to be located on this C-terminal fragment is destroyed by pronase or by treatments such as periodate oxidation or galactose oxidase-bromine oxidation which modify the carbohydrate moieties. Thus, both amino acid and carbohydrate residues are involved in the structure of the antigenic determinant.
D000595:Amino Acid Sequence; D000818:Animals; D001980:Bronchi / Q000276:immunology*; D002850:Chromatography, Gel; D000939:Epitopes; D005692:Galactose Oxidase; D006801:Humans; D008970:Molecular Weight; D009077:Mucins / Q000276:immunology* / Q000302:isolation & purification; D010446:Peptide Fragments / Q000302:isolation & purification; D010504:Periodic Acid; D011402:Pronase; D011817:Rabbits; D014357:Trypsin
D000939:Epitopes; D009077:Mucins; D010446:Peptide Fragments; D010504:Periodic Acid; D005692:Galactose Oxidase; D014357:Trypsin; D011402:Pronase